BioGenerator-supported digital health company wins $20k cash + contract Phas3, a St. Louis-based company providing remote cardiac rehab, has won Colorado’s Prime Health Challenge, which will allow Phas3 to pilot its […]
Read MoreCanopy Biosciences, a 2-year-old St. Louis company providing genomics products and services, made its second acquisition this week. Canopy announced Wednesday that it bought Core Diagnostics, a Hayward, California, provider of biomarker […]
Read MoreBioGenerator-backed company is first to manufacture digital health device in St. Louis St. Louis digital health company Readout Health is set to help millions of people manage their health through […]
Read MoreCrop Innovation Company Introduces New Seed Company Focused on High-Performance Food & Feed Grade Soybeans Growers can tap into growing markets with expanded offerings of high-quality, high-yielding varieties ST. LOUIS, […]
Read MoreST. LOUIS, Dec. 4, 2019 /PRNewswire/ — Canopy Biosciences, LLC announced today the acquisition of Core Diagnostics, a leading CLIA-certified provider of biomarker analysis services for biopharmaceutical researchers. With the […]
Read MoreST. LOUIS – St. Louis talent and St. Louis investment have led Healthy Bytes to relocate its headquarters from New York to St. Louis. With investments from Cultivation Capital and […]
Read MoreGalera Therapeutics has raised a $60 million in an initial public offering. The company, which is developing treatments to reduce the harmful effect of radiation therapy, raised the $60 million […]
Read MoreBioGenerator is seeking qualified candidates to join our team and help us achieve our mission of promoting economic growth and regional prosperity. BioGenerator, the non-profit investment arm of BioSTL, was […]
Read MoreIndalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965 October 21, 2019 Key milestone reached in adaptive Phase 1/1b clinical trial that began in April 2019 […]
Read MoreBioGenerator portfolio company noted for its ‘promising technology’ to more quickly and affordably bring vaccines to market ST. LOUIS – St. Louis bioscience startup VaxNewMo is developing broader and more affordable vaccines […]
Read More